Indeed, rmSIRT1 reduced both hepatic steatosis and atherosclerotic phenotype in the ApoE−/− mice, therefore our study might be a first step towards establishing circulating SIRT1 as a potent therapeutic against the global lipid burden. This evidence concerns the gene APOE and fatty liver disease.